5Suppliers
3Customers
1Debt Items
20Related Chains

Source-Backed Evidence Depth

NuCana plc (NCNA) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

10Total relationships
2Distinct source URLs
4High confidence
0.782Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

NuCana plc Suppliers

TickerNameConfidenceEvidence
EUROPEAN-UNION EUROPEAN-UNION 90% we source our active pharmaceutical ingredient, or API, and other raw materials and our research and development, manufacturing, consulting and other services worldwide, including from the European Union
INDIA INDIA 90% we source our active pharmaceutical ingredient, or API, and other raw materials and our research and development, manufacturing, consulting and other services worldwide, including from India
ORANY ORANY 72% log standards of care. We are working to identify and quantify key biomarkers relevant to NUC-7738 and NUC-3373, as well as to assess their predictive nature with regard to treatment. In addition, su…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from NCNA graph: log standards of care. We are working to identify and quantify key biomarkers relevant to NUC-7738 and NUC-3373, as …
VRAX Virax Biolabs Group Limited 72% Reciprocal relationship from VRAX graph: regular healthcare consulting are still hindrances in some regions, especially third-world countries, which impedes the growth of the IVD market. Key Supplier…

NuCana plc Customers

TickerNameConfidenceEvidence
ORANY ORANY 72% log standards of care. We are working to identify and quantify key biomarkers relevant to NUC-7738 and NUC-3373, as well as to assess their predictive nature with regard to treatment. In addition, su…
ORANY ORANY 72% Reciprocal relationship from ORANY graph: Reciprocal relationship from NCNA graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from NCNA graph: Reciprocal relationship from ORAN…
UK-LTD UK-LTD 62% it was primarily attributable to a decrease in our eligible research and development expenses. Comparison of Year Ended December 31, 2023 and 2024 The discussion of our operating results for the year…

NuCana plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
NCNA-DEBT Debt stack $909,323 90% Market cache reports total debt of $909,323.

NuCana plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for NuCana plc.

NuCana plc Ownership

HolderNameConfidenceEvidence
NCNA-OWNER-DANSKE-BANK-A-S DANSKE BANK A/S 90% 13F overlay lists DANSKE BANK A/S as top holder; 1 tracked holders.

NuCana plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
VRAX Virax Biolabs Group Limited 100.00 1 ['supplier']
QGEN Qiagen N.V. 100.00 2
ABT Abbott Laboratories 100.00 2
ORANY ORANGE 100.00 1 ['customer', 'supplier']
ASBPW Aspire Biopharma Holdings, Inc. 50.00 2
BFRGW BullFrog AI Holdings, Inc. 50.00 2
BCDRF Banco Santander, S.A. 50.00 2
AMZE Amaze Holdings, Inc. 50.00 2
BLTE Belite Bio, Inc 50.00 2
CPRX Catalyst Pharmaceuticals, Inc. 50.00 2
ARQQW Arqit Quantum Inc. 50.00 2
AYTU Aytu BioPharma, Inc. 50.00 2
CYCN Cyclerion Therapeutics, Inc. 50.00 2
CMCM Cheetah Mobile Inc. 50.00 2
DARE Daré Bioscience, Inc. 50.00 2
BFRIW Biofrontera Inc. 50.00 2
CINGW Cingulate Inc. 50.00 2
EPDU ENTERPRISE PRODUCTS PARTNERS L.P. 50.00 2
CYTOF Altamira Therapeutics Ltd. 50.00 2
D Dominion Energy, Inc. 50.00 2
🔐
NCNA
Unlock NCNA Supply Chain Data
Verified relationships include:
EUROPEAN-UNIONEUROPEAN-UNIONSupplier90%
INDIAINDIASupplier90%
ORANYORANYCustomer72%
ORANYORANYCustomer72%
+6 more relationships locked
Subscribe, View plans →